Skip to content

Evaluation of the Causes and Disease Processes of Chronic Lung Disease

Comprehensive Evaluation of the Etiology and Pathogenesis of Chronic Lung Disease (Screening Protocol)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00001183
Enrollment
6564
Registered
1999-11-04
Start date
1984-11-18
Completion date
2019-12-16
Last updated
2022-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Disease

Keywords

Computed Tomography, Fiberoptic Bronchoscopy, Pulmonary Function Testing, Cardiopulmonary Exercise Testing, Allergen Skin Testing

Brief summary

Chronic lung diseases are disorders associated with abnormalities in any of the structures involved in the process of breathing and bringing oxygen into the lungs and blood. This includes abnormalities in the airways, lungs, blood vessels in and around the lungs, and the tissue covering the lungs (pleura). The purpose of this research study is to evaluate patients referred to the Cardiovascular and Pulmonary Branch of the National Heart, Lung, and Blood Institute (NHLBI) in order to; 1. Develop a better understanding of the causes and disease processes involved in disorders of the lungs 2. Identify patients eligible to participate in other P-CCMB research studies

Detailed description

The chronic lung diseases are those disorders associated with functional and/or structural derangement to the alveolar structures, airways, pulmonary blood vessels, pleura and/or mediastinum. The purpose of this project is to permit the comprehensive evaluation of patients referred to the Pulmonary Branch of the National Heart, Lung, and Blood Institute (NHLBI) in order to: (1) develop an understanding of the etiology and pathogenesis of these disorders; and (2) identify individuals who will be suitable candidates for other NHLBI protocols. Testing and procedures will only be performed when medically indicated for the purposes of making a diagnosis or obtaining information likely to be useful in the management of the subjects' disease or condition.

Interventions

None listed

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
Lead SponsorNIH

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
7 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* INCLUSION CRITERIA: Symptoms consistent with pulmonary disease. May have family history of lung disease. Patients with diseases of organs with known association with lung disease. Ranging in age from 7 to 90 years old. Pregnant and nursing women may participate in minimal risk procedures

Exclusion criteria

Persons with no clinical evidence of lung disease.

Design outcomes

Primary

MeasureTime frameDescription
N/A-screening protocol1 VisitEvaluate

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026